{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:10:31Z","timestamp":1781032231670,"version":"3.54.1"},"reference-count":50,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                    sequence type (ST) 131 is considered a high-risk pandemic clone and frequently extended-spectrum \u03b2-lactamase (ESBL)-producing clone that is strongly associated with the global dissemination of CTX-M-15 type. The emergence of ST131 has become a public health threat because this clonal group typically exhibits multiple virulence factors and antimicrobial resistance. Therefore, this study aimed to analyze the literature published on the estimation of the prevalence of clone ST131 among\n                    <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                    strains isolated from patients with urinary tract infections in western Asia. A systematic search was carried out to identify eligible articles in the Web of Science, PubMed, Scopus, Embase, and Google Scholar electronic databases from January 2010 to December 2018. Next, 13 articles meeting the inclusion criteria were selected for data extraction and analysis by Comprehensive Meta-Analysis Software. The included studies were conducted in Iran, Jordan, Kuwait, Pakistan, Saudi Arabia, Turkey, and Yemen. In all studies, the pooled prevalence of ST131 was 24.6% (95% CI: 13.5%\u201340.4%) in wild type isolates, 42.7% (95% CI: 32.5%\u201353.5%) among ESBLs-producing isolates, and 64.8% (95% CI: 36%\u201385.5%) among multiple-drug resistant (MDR) isolates. Moreover, the prevalence of ST131 isolates carrying CTX-M-15 type was 68% (95% CI: 48.4%\u201382.8%). Our study indicated the high prevalence of broadly disseminated ST131 clone among MDR and ESBLs isolates in western Asia. Moreover, O25b was the predominant ST131 clone type, which was mostly associated with CTX-M-15 type.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2019.0312","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T03:13:42Z","timestamp":1588907622000},"page":"1357-1364","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Emergence of\n                    <i>Escherichia coli<\/i>\n                    ST131 Causing Urinary Tract Infection in Western Asia: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"26","author":[{"given":"Alireza","family":"Jafari","sequence":"first","affiliation":[{"name":"Urology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash","family":"Falahatkar","sequence":"additional","affiliation":[{"name":"Urology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourosh","family":"Delpasand","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Sabati","sequence":"additional","affiliation":[{"name":"Biotechnology and Biological Science Research Center, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Sedigh Ebrahim-Saraie","sequence":"additional","affiliation":[{"name":"Razi Clinical Research Development Unit, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv429"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3467-0"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S219696"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw102"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00110"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.aambs.2014.09.002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.02.017"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0021"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00732-17"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209580"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33093-8"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.06.017"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008162"},{"key":"e_1_3_4_15_2","first-page":"e00470","volume":"9","author":"Liu C.M.","year":"2018","unstructured":"Liu C.M., , Stegger M., , Aziz M., , Johnson T.J, , Waits K., , Nordstrom L., , Gauld L., , Weaver B., , Rolland D., , Statham S., , Horwinski J., , Sariya S., , Davis G.S, , Sokurenko E., , Keim P., , Johnson J.R, , and Price L.B.. 2018. Escherichia coli ST131-H22 as a Foodborne Uropathogen. mBio. 9:e00470-18.","journal-title":"Escherichia coli ST131-H22 as a Foodborne Uropathogen. mBio"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2013.1608"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2015.1936"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2016.0272"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0274-0"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01941"},{"key":"e_1_3_4_21_2","unstructured":"Joanna Briggs Institute. 2017. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews: Checklist for Prevalence Studies. Joanna Briggs Institute. Available at: https:\/\/joannabriggs.org\/ebp\/critical_appraisal_tools"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-1970-1"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-13-4"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-014-0214-6"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2015.10.006"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu864"},{"key":"e_1_3_4_27_2","first-page":"2757","volume-title":"J. Antimicrob. Chemother","author":"Alghoribi M.F.","year":"2015","unstructured":"Alghoribi M.F., , Gibreel T.M, , Farnham G., , Al Johani S.M, , Balkhy H.H, , and Upton M.. 2015. Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia. J. Antimicrob. Chemother. 70:2757\u20132762."},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-016-0177-6"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3021-9"},{"key":"e_1_3_4_30_2","first-page":"1661","volume":"75","author":"Atac N.","year":"2018","unstructured":"Atac N., , Kurt-Azap O., , Dolapci I., , Yesilkaya A., , Ergonul O., , Gonen M., , and Can F.. 2018. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131. Curr. Microbiol. 75:1661\u20131666.","journal-title":"The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131. Curr. Microbiol"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2018.0024"},{"key":"e_1_3_4_32_2","first-page":"1","volume":"12","author":"Nairoukh Y.R.","year":"2018","unstructured":"Nairoukh Y.R., , Mahafzah A.M, , Irshaid A., , and Shehabi A.A.. 2018. Molecular Characterization of Multidrug Resistant Uropathogenic E. coli Isolates from Jordanian Patients. Open Microbiol. J. 12:1\u20137.","journal-title":"Molecular Characterization of Multidrug Resistant Uropathogenic E. coli Isolates from Jordanian Patients. Open Microbiol. J"},{"key":"e_1_3_4_33_2","first-page":"13","article-title":"[Investigation of high-risk ST131 clone in ESBL-producing Escherichia coli isolates isolated from urine and non-urinary clinical specimens with MALDI-TOF MS and real time PCR]","volume":"52","author":"Cizmeci Z.","year":"2018","unstructured":"Cizmeci Z., , Otlu B., , Aktas E., , Ordekci S., , Acikgoz O., , and Gulec N.. 2018. [Investigation of high-risk ST131 clone in ESBL-producing Escherichia coli isolates isolated from urine and non-urinary clinical specimens with MALDI-TOF MS and real time PCR]. Mikrobiyol. Bul. 52:13\u201322.","journal-title":"Mikrobiyol. Bul"},{"key":"e_1_3_4_34_2","first-page":"286","volume":"51","author":"Johnson J.R.","year":"2010","unstructured":"Johnson J.R., , Johnston B., , Clabots C., , Kuskowski M.A, , and Castanheira M.. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286\u2013294.","journal-title":"Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00125-13"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.12.006"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00243"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00297-09"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2017.60.7.221"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000179"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.02.020"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01099-12"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000623"},{"key":"e_1_3_4_44_2","first-page":"2125","volume-title":"J. Antimicrob. Chemother","author":"Merino I.","year":"2016","unstructured":"Merino I., , Shaw E., , Horcajada J.P, , Cercenado E., , Mirelis B., , Pallares M.A, , Gomez J., , Xercavins M., , Martinez-Martinez L., , De Cueto M., , Canton R., , and Ruiz-Garbajosa P.. 2016. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain. J. Antimicrob. Chemother. 71:2125\u20132130."},{"key":"e_1_3_4_45_2","first-page":"1327","volume-title":"Antimicrob. Agents Chemother","author":"Peirano G.","year":"2010","unstructured":"Peirano G., , Richardson D., , Nigrin J., , McGeer A., , Loo V., , Toye B., , Alfa M., , Pienaar C., , Kibsey P., , and Pitout J.D. 2010. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 54:1327\u20131330."},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn463"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2015.12.010"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04772-14"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00688-09"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S206966"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30414-6"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2019.0312","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2019.0312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2019.0312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:36:33Z","timestamp":1777667793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/mdr.2019.0312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["10.1089\/mdr.2019.0312"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2019.0312","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]}}}